Araclon Biotech
Company Details
Status: Private
Employees: 11-50
Location:
Zaragoza
Type:
sample
sample
sample
Technology:
sample
sample
About: Araclon Biotech S.L. is a biotechnology company founded by Pr. Manuel Sarasa.
Araclon Biotech is a company dedicated to the research and development of therapies and diagnostic methods to be applied to degenerative diseases, currently focusing on Alzheimer’s disease. At present, Araclon is working on four different projects:
The first of these focuses on the diagnosis of Alzheimer’s disease (with a detection kit for beta-amyloid 40 and 42 proteins in blood already patented).
The second is centred on Alzheimer’s therapy (immunotherapy based).
The third is an emerging project, which attempts to respond to the challenge of predicting Alzheimer’s disease in totally asymptomatic individuals.
And finally, a project related to the development of a therapy for the Parkinson’s disease.
Our mission
To research and develop immunotherapies and diagnostic methods used in the treatment of degenerative diseases. It is our aim to provide effective solutions for such diseases.
Our objectives
Within the area of degenerative diseases, we are currently focused on Alzheimer’s disease. As such, our initial objectives are:
Validation and global marketing of a diagnostic blood test for Alzheimer’s disease.
Development of effective immunotherapy against Alzheimer’s disease.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Araclon Biotech | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.